Climate change and pavement burns in the United Kingdom: a case report of two patients.

Pavement burns are more common in locations familiarised with high temperatures and a dry climate zone, but have not previously been reported in temperate climates. We present two cases of patients who suffered pavement burns in the United Kingdom during an unprecedentedly hot day in July 2022. The first case involved a 66-year-old male who suffered partial and full thickness burns requiring excision and skin grafting. The second case involved a 58-year-old female with partial thickness burns also requiring excision and skin grafting. Both patients had pre-existing co-morbidities and their pavement burns were precipitated by heat stroke. Pavement burns represent a mechanism of injury that necessitates increased operative management, length of hospital stay and cost per surface area burned when compared to flame or scald burns (Silver et al., 2015). As a result of global warming, we anticipate extreme heat events, and subsequently pavement burns, to increase in incidence in the United Kingdom. There is opportunity for education of the public and health professionals for prevention.

The explicit learning of new names for known objects is improved by dexamphetamine.

A randomised, double-blind, placebo-controlled, between subjects study design (N=37) was used to investigate the effects of dexamphetamine on explicit new name learning. Participants ingested 10mg of dexamphetamine or placebo daily over 5 consecutive mornings before learning new names for 50 familiar objects plus fillers. The dexamphetamine group recognised and recalled the new names more accurately than the placebo group over the 5 days and 1 month later. Word learning success was not associated with baseline neuropsychological performance, mood, cardiovascular arousal, or sustained attention. These results may have implications for the pharmacological treatment of acquired naming difficulties.

Effect of aging on learning new names and descriptions for objects.

The present study consisted of two experiments to compare new word learning in healthy young (N?=?11) and older (N?=?17) adults within an explicit learning paradigm. Experiment 1 investigated the new name learning for familiar objects, while Experiment 2 investigated learning names and descriptions for unfamiliar objects. Participants attended five learning sessions over 5 consecutive days, during which they viewed objects with novel names with/without descriptions. The older adults were as accurate as the young adults when recalling and recognizing new names during the learning sessions. With respect to response times, the older adults were as rapid as the young adults at recognizing the new names for the familiar objects, but were slower during the follow-up sessions. The older adults were also slower when recognizing new names for unfamiliar objects. When recognizing unfamiliar object descriptions, the older adults were significantly less accurate than the young adults. These results may have implications for the treatment of acquired naming difficulties and second language learning in older adults.

Dexamphetamine enhances explicit new word learning for novel objects.

Past research suggests that dexamphetamine (Dex) can facilitate learning and memory in healthy individuals and after a neurological lesion. This study investigated the effects of Dex on the learning of names for new objects in young healthy adults (n=37) within an explicit learning paradigm by using a double-blind, placebo-controlled between- subjects design. Participants received 10 mg Dex or a placebo each morning over five consecutive days before viewing 100 novel objects with non-word names plus matched fillers. Compared to the placebo, Dex enhanced both the rate of learning and the retention of the words 1 wk and 1 month later. The improved word learning correlated with baseline attention and memory scores for participants in the Dex group only. No correlations were observed between word-learning success and sustained attention, mood or cardiovascular arousal. It was concluded that the improved explicit word learning may have reflected dexamphetamine-induced changes in short-term memory and/or memory consolidation.

Dexamphetamine boosts naming treatment effects in chronic aphasia.

To date, minimal research has investigated the effect of combining dexamphetamine with standard naming therapy after stroke. The present study used a double-blind, placebo-controlled, multiple baseline, crossover design with two individuals in the chronic stage of stroke recovery. Each individual attended two 4-week blocks of naming therapy (two to three treatment sessions per week). Dexamphetamine (10 mg) was administered at the start of each session during one therapy block, while a placebo was administered during the other therapy block. Therapy progress on treated and untreated items was assessed by a confrontation naming task during and after each therapy block. Both individuals showed greater progress in therapy and maintenance of therapy gains when behavioral treatment was combined with dexamphetamine rather than placebo, although this gain was only statistically significant in one individual. There was no significant improvement on a control task (nonword reading) in either individual. The results provide preliminary evidence that dexamphetamine paired with combined semantic and phonological therapy may be beneficial for the treatment of naming disorders in chronic aphasia.